Srdjan R. Stankovic - Oct 15, 2022 Form 4 Insider Report for ACADIA PHARMACEUTICALS INC (ACAD)

Role
President
Signature
/s/ Austin D. Kim, Attorney-in-Fact
Stock symbol
ACAD
Transactions as of
Oct 15, 2022
Transactions value $
-$20,964
Form type
4
Date filed
10/18/2022, 09:22 PM
Previous filing
May 3, 2022
Next filing
Nov 22, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ACAD Common Stock Options Exercise +2.97K +5.38% 58.2K Oct 15, 2022 Direct F1
transaction ACAD Common Stock Sale -$21K -1.33K -2.28% $15.81 56.8K Oct 15, 2022 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ACAD Restricted Stock Units Options Exercise $0 -2.97K -100% $0.00* 0 Oct 15, 2022 Common Stock 2.97K Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
F2 The sales reported in this Form 4 were made to cover the tax obligation that occurred upon the vesting of restricted stock units.
F3 The restricted stock units vest in four equal annual installments beginning 10/15/19.